Pandemic influenza and pregnant women

Emerging Infectious Diseases

Volumn 14, Issue 1, 2008, Pages 95-100

  Rasmussen, Sonja A ^a   Jamieson, Denise J ^a   Bresee, Joseph S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELIVERY; EXPOSURE; FEVER; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; NONHUMAN; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL CARE; REVIEW;

EID: 38049016832     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1401.070667     Document Type: Review

References (40)

1. Taubenberger JK, Morens DM, Fauci AS. The next influenza pandemic: can it be predicted? JAMA. 2007;297:2025-7.
2. World Health Organization Global Influenza Program Surveillance Network. Confirmed human cases of avian influenza A (H5N1). [cited 2007 Aug16]. Available from http://www.who.int/csr/disease/avian_influenza/country/en/index.html
3. US Department of Health and Human Services. HHS pandemic influenza plan. [cited 2007 Feb 27]. Available from http://www.hhs.gov/pandemicflu/plan/pdf/ HHSPandemicInfluenzaPlan.pdf
4. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094-102.
5. Harris JW. Influenza occurring in pregnant women. JAMA. 1919;72:978-80.
6. Nuzum JW, Pilot I, Stangl FH, Bonar BE. Pandemic influenza and pneumonia in a large civilian hospital. JAMA. 1918;71:1562-5.
7. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172-5.
8. Hardy JM, Azarowicz EN, Mannini A, Medearis DN Jr, Cooke RE. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health. 1961;51:1182-8.
9. Acs N, Banhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol. 2005;73:989-96.
10. Coffey VP, Jessop WJ. Maternal influenza and congenital deformities. A follow-up study. Lancet. 1963;1:748-51.
11. Saxen L, Hjelt L, Sjostedt JE, Hakosalo J, Hakosalo H. Asian influenza during pregnancy and congenital malformations. Acta Pathol Microbiol Scand. 1960;49:114-26.
12. Wilson MG, Stein AM. Teratogenic effects of Asian influenza. An extended study. JAMA. 1969;210:336-7.
13. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33:S390-7.
14. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12:1638-43.
15. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007;56:1-54.
16. Mullooly JP, Barker WH, Nolan TF Jr. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep. 1986;101:205-11.
17. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006;107:1315-22.
18. Zou S. Potential impact of pandemic influenza on blood safety and availability. Transfus Med Rev. 2006;20:181-9.
19. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG. 2000;107:1282-9.
20. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH, et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol. 2002;22:25-33.
21. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci. 2003;23:297-302.
22. Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int J Dev Neurosci. 2005;23:299-305.
23. Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007;165:27-35.
24. Ebert T, Kotler M. Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J. 2005;7:35-8.
25. Takahashi M, Yamada T. A possible role of influenza A virus infection for Parkinson's disease. Adv Neurol. 2001;86:91-104.
26. Edwards MJ. Review: hyperthermia and fever during pregnancy. Birth Defects Res A Clin Mol Teratol. 2006;76:507-16.
27. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16:216-9.
28. Suarez L, Felkner M, Hendricks K. The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol. 2004;70:815-9.
29. Shaw GM, Nelson V, Carmichael SL, Lammer EJ, Finnell RH, Rosenquist TH. Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology. 2002;13:625-30.
30. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology. 1998;57:1-7.
31. Botto LD, Erickson JD, Mulinare J, Lynberg MC, Liu Y. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology. 2002;13:485-8.
32. Centers for Disease Control and Prevention. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States-early, targeted, layered use of nonpharmaceutical interventions [cited 2007 Mar 3]. Available from http:// www.pandemicflu.gov/plan/community/ community_mitigation.pdf
33. Jamieson DJ, Ellis JE, Jernigan DB, Treadwell TA. Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician- gynecologists. Am J Obstet Gynecol. 2006;194:1546-55.
34. Owolabi T, Kwolek S. Managing obstetrical patients during severe acute respiratory syndrome outbreak. J Obstet Gynaecol Can. 2004;26:35-41.
35. Cono J, Cragan JD, Jamieson DJ, Rasmussen SA. Prophylaxis and treatment of pregnant women during emerging infections and bioterorism emergencies. Emerg Infect Dis. 2006;12:1631-7.
36. Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005;55(Suppl 1):i5-21.
37. Freund B, Gravenstein S, Elliott M, Miller I. Zanamivir: a review of clinical safety. Drug Saf. 1999;21:267-81.
38. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355:827-35.
39. Schunemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG, et al. WHO rapid advice guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis. 2007;7:21-31.
40. American College of Obstetrician and Gynecologists (ACOG) Committee on Obstetric Practice. Influenza vaccination and treatment during pregnancy. ACOG committee opinion no. 305, November 2004. Obstet Gynecol. 2004;104:1125-6.